Investing, Economy, Stocks, Real estate, Apple, Google, Inflation, Retirement, China, Housing, Oil, Banks, Interest rates, Recession, Iphone, Housing bubble, Personal finance, Countrywide, Credit, Credit crunch, Stock market, Federal reserve, Dividend, Banking, Bank of america.
Related Tags: Sgp, Zetia, Vytorin, Merck, Azn, Crestor, Pfe, Schering plough, Vioxx, Zocor, Statins, Pfizer, Defibrillators, Cordaptive, Plough, Cetp, Gdt, Prasugrel, Lipitor, Vaccines, Cancer, Mdt, Cvtx, Simcor, Schering-plough.
Merck and Schering are way up from their recent lows- and AZN is off its recent highs. There is more money to be made here, but making the same trades I recommended last week.
Buying AZN is the best way to play enhance if you didn't short MRK and SGP
Even more fall out today from the Enhance trial at the ACC today.
While Merck and Schering Plough have already fallen hard, they should both continue to fall for the forseeable future
Merck and Schering Plough has finally released the ENHANCE trial. The results were bad- and the cover up was worse. Look out for falling stocks. Timber....
More bad news for MRK and SGP. This article in today's NYTimes suggests that the companies have been hiding research showing long term risk to combining Zetia with statins. IS this another Vioxx-...
Apparently, Congress isn't happy with the games Merck and Schering Plough are playing with their trial data on Zetia. I wrote about how they have been delaying release of this trial and are...
Merck and Schering Plough seem to be doing everything they can to protect their popular drugs from the results of a trial they designed and ran.
More bad news for MRK and SGP. A presentation which hadn't gathered any pre-meeting publicity shows that cutting zetia in half can half costs, while not altering affect on lipids.
Here is how I anticipate the big trials out of the AHA panning out and how you can trade based on these projected results
Medtronic has had a bad week- their stock went down on good news regarding their drug eluting stent and now today the stock plummeted on news of the withdrawal from the market of their ICD leads.
Merck just released phase II data on a drug called a CETP. The stock has been moving up- at least partially on this news. This drug is very unlikely to ever reach the market. I don't understand...
Although for some time now many thought Merck was an easy short, given Vioxx and the large number of law suits and settlements before it, the company had a strategy in place to rise again. And,...
| Page 1 of 1 |
BestCashCow provides information on the best CD (certificates of deposit) rates, the best money market rates, the best savings rates, and more - as well as financial information that can help you make better decisions with your money.
|
Type
|
Interest Rate
|
Institution
|
|
4.76%
|
EverBank
|
|
|
2.55%
|
Fidelity
|
|
|
3.56%
|
Corus Bank
|
|
|
4.25%
|
Corus Bank
|
|
|
5.00%
|
Washington Mutual
|
|
|
4.38%
|
Geauga Bank
|
|
|
4.50%
|
Wachovia Bank
|
|
|
4.81%
|
Discover Bank
|
|
|
5.23%
|
Discover Bank
|
|
|
4.84%
|
US Treasury
|
|
|
3.50%
|
Federal Home Loan Bank (state and local tax exempt)
|
|
|
3.28%
|
Northrop Grumman FCU
|
|
|
4.06%
|
Melrose CU
|
|
|
4.22%
|
Melrose CU
|
|
|
4.32%
|
Melrose CU
|
|
|
1.83%
|
Various brokerages
|
|
|
2.01%
|
Various brokerages
|
|
|
2.38%
|
Various brokerages
|
|
|
3.10%
|
Various brokerages
|
|
|
3.84%
|
Various brokerages
|
See more product and rate information
Where do you think Interest rates are going?
